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Abstract 
 
Background: This study aimed to evaluate eye-movement 
desensitisation and reprocessing (EMDR) as a treatment for obsessive-
compulsive disorder (OCD), by comparison to cognitive behavioural 
therapy (CBT) based on exposure and response prevention. 
Method: This was a pragmatic, feasibility randomised controlled trial 
in which 55 participants with OCD were randomised to EMDR (n = 29) 
or CBT (n = 26). The Yale-Brown obsessive compulsive scale (YBOCS) 
was completed at baseline, after treatment and at 6 months follow-up. 
Treatment completion and response rates were compared using chi 
square tests. Effect size was examined using &RKHQ·Vd and multilevel 
modelling. 
Results: Overall, 61.8% completed treatment and 30.2% attained 
reliable and clinically significant improvement in OCD symptoms, with 
no significant differences between groups (p > .05). There were no 
significant differences between groups in YBOCS severity post-
treatment (d = -0.24, p = .38) or at 6 months follow-up (d = -0.03, p = 
.90).  
Conclusions: EMDR and CBT had comparable completion rates and 
clinical outcomes. 
 
Key Practitioner Message 
)LIW\ILYHSDWLHQWVZLWK2&'ZHUHUDQGRPLVHGWRUHFHLYHHLWKHU(0'5
or CBT 
 %RWK WUHDWPHQWV KDG FRPSDUDEOH FRPSOHWLRQ UDWHV DQG FOLQLFDO
outcomes 
1RVLJQLILFDQWGLIIHUHQFHVZHUHIRXQGDIWHUWUHDWPent or at 6 months 
follow-up 
 
Key words: EMDR; CBT; obsessive-compulsive disorder; randomized 
controlled trial 
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INTRODUCTION 
 
Obsessive-Compulsive Disorder (OCD) is a condition characterised by 
intrusive thoughts (obsessions) that are accompanied by intense urges 
(compulsions) to neutralise the associated distress by performing 
mental or physical rituals (Abramowitz, Taylor, & McKay, 2009). 
Cognitive behavioural therapy (CBT) based on exposure and response 
prevention (ERP) is recommended by clinical guidelines as a first line 
psychological treatment for this condition (National Institute for 
Health and Clinical Excellence [NICE], 2005). Meta-analytic reviews of 
clinical trials indicate that CBT is significantly more effective than 
waitlist or placebo control conditions and equally as effective as 
pharmacological treatment (i.e., Abramowitz, 1997, 1998; van Balkom 
et al., 1994; Olatunji, Davis, Powers, & Smits, 2013). In spite of the 
evidence favouring CBT, there are also a number of recognised 
drawbacks. Some studies suggest that patients find it difficult to 
tolerate exposure exercises and tend to drop out of treatment 
(Abramowitz, Taylor, & McKay, 2005). For example, Foa et al. (2005) 
reported that 28% of patients dropped out shortly after commencing 
exposure and response prevention. Even after completing CBT, more 
than 30% of patients are reported to access ongoing treatment (Rowa 
et al., 2007). Furthermore, OCD is considered to be one of the most 
treatment resistant non-psychotic mental health problems (Ponniah, 
Magiati, & Hollon, 2013), since relatively few patients (approximately 
25%) end treatment completely symptom-free (Fisher & Wells, 2005). 
These drawbacks raise a question about how to meet the needs of 
those for whom CBT is less effective.  
Recent studies have considered whether eye-movement 
desensitisation and reprocessing (EMDR) could be a helpful 
alternative treatment for OCD. EMDR is an empirically supported 
treatment for post-traumatic stress disorder (Bisson et al., 2007; 
Davidson, & Parker, 2001; Van Etten, & Taylor, 1998). A number of 
uncontrolled case series have reported the successful application of 
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EMDR to alleviate symptoms of OCD (Bekkers, 1999; Bohm & 
Voderholzer, 2010; Keenan, et al., 2014; Marr, 2012). Furthermore, 
Nazari et al. (2011) conducted a controlled trial in which 90 OCD 
patients were randomised to either EMDR or pharmacotherapy 
(citalopram). This trial reported comparable baseline severity of OCD 
symptoms using the Yale-Brown Obsessive Compulsive Scale 
(YBOCS), but significantly lower symptoms in the EMDR group (mean 
YBOCS = 13.6) by comparison to the pharmacotherapy group (mean 
YBOCS = 19.06) after 12 weeks of treatment.  
Furthermore, there are theoretical reasons why EMDR could be 
considered as a plausible treatment option for OCD. There is evidence 
that in some cases OCD may originate in the wake of stressful life 
events (de Silva & Marks, 1999), and that stressful life events increase 
the risk of OCD relapse (Steketee, 1993). For example, there is a high 
incidence of OCD in combat exposed soldiers by comparison to 
controls (Jordan et al., 1991), and the risk of developing OCD is ten 
times greater in people with post-traumatic stress disorder by 
comparison to people without trauma-related problems (Helzer et al., 
1987). The adaptive information processing (AIP) model of EMDR 
proposes that psychological symptoms often result from unprocessed 
traumatic material (Shapiro & Forrest, 2004), or stressful life events. 
Based on the notion that EMDR works to resolve disturbing memories 
of traumatic events, it could be that other types of anxiety disorders 
that develop following a distressing event may also be responsive to 
EMDR. OCD, whilst different in presentation to PTSD, shares some 
similarities such as repeated intrusive thoughts and images that 
evoke intense anxiety and avoidance. Several case studies have also 
indicated qualitative/metaphorical associations between the content 
RIREVHVVLYHLQWUXVLRQVHJ¶EHLQJRUIHHOLQJGLUW\·DQGWKHFRQWH[WRI
traumatic events (e.g., sexual assault) implicated in the onset of 
obsessional thoughts (de Silva & Marks, 1999). It seems plausible that 
processing the cognitive, somatic and affective aspects of traumatic 
 5 
events could afford some alleviation of symptoms that may have 
arisen from such events.  
Overall, these emerging studies and hypotheses suggest that 
EMDR could be a helpful treatment option for OCD, although there 
are also several caveats. Small case series are not representative of 
OCD cases in general healthcare settings and could be prone to 
selection biases. These case series also lack rigorous designs (i.e., 
single case experimental design with multiple baselines) and 
appropriate statistics to account for regression to the mean. The only 
experimental study to date by Nazari et al. (2011) offers more 
convincing support for the application of EMDR; however, the lack of 
post-treatment follow-up raises questions about the sustainability of 
treatment effects. Furthermore, it is not known if EMDR may be as 
effective or acceptable as commonly available CBT interventions. 
With this backdrop of emerging studies, we conducted a 
controlled trial that enabled us to compare the application of EMDR 
with CBT for OCD. 
 
METHOD 
 
Design 
 
This was a pragmatic randomised controlled trial conducted in a 
primary care, outpatient, public healthcare system (UK National 
Health Service). The primary objective was to assess the feasibility 
(based on attendance and completion rates) of delivering EMDR for 
OCD in routine care. A secondary objective was to undertake a 
preliminary comparison of clinical effects between EMDR and CBT, 
which could inform future trials assessing efficacy and mechanisms of 
action. 
The study was approved by an NHS research ethics committee 
(Ref: 13/YH/0338) and registered in an international database prior to 
recruitment (ISRCTN16396325). 
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Setting 
 
Trial participants were recruited and treated in a primary care mental 
health service in Leeds, a large and socioeconomically diverse city in 
the north of England. The service offered access to evidence-based 
psychological interventions recommended by national guidelines 
(NICE, 2011) and delivered by qualified practitioners working under 
clinical supervision. Patients with OCD were referred to the service by 
general practitioners, or self-referred, and were routinely offered 16 to 
20 sessions of cognitive behavioural therapy (NICE, 2005). 
 
Interventions 
 
Eye-Movement Desensitisation and Reprocessing (EMDR) 
EMDR is a therapy where a structured approach is used to address 
the past, present and future aspects of traumatic events. Based on 
Shapiro's (2001) AIP model, EMDR conceptualises psychiatric 
disorders as a manifestation of unresolved traumatic events. EMDR 
therapy uses a eight-phase procedure that begins with history taking 
and case formulation (phase 1), preparation (phase 2) to ensure the 
client has the resources to manage the processing of the distressing 
information to an adaptive resolution. In phase 3 the visual, cognitive 
(negative and desired positive cognition), affective, and sensory 
components of the targeted memory are identified, and ratings for 
levels of distress and level of belief in the positive cognition are taken. 
In phase 4, the client recalls the targeted memory, while 
simultaneously engaging in sets of eye movements (or alternating 
bilateral audio and/or tactile stimulation). This continues until the 
distress level is rated at 0. A memory is considered to be processed 
when it no longer elicits any affective or somatic distress. In phase 5 
the transition to a convincingly valid positive cognition is strengthened 
using further bilateral stimulation (for example, going from a negative 
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FRJQLWLRQRI¶,DPSRZHUOHVV·WR¶,DPLQFRQWURO· The installation and 
strengthening of the positive cognition is a crucial component of 
EMDR by IRFXVLQJ RQ WKH FOLHQW·V SRVLWLYH VHOI-assessment which is 
pivotal for positive therapeutic effect (Shapiro 2001). Phase 6 is 
considered completed when a client can bring the memory and 
positive cognition to mind without any body tension. Phase 7 involves 
a careful closure of the session including use of resources, and phase 
8 is the re-evaluation which takes place at the start of every 
subsequent session.  
Marr (2012) hypothesised that EMDR could provide a treatment 
option for OCD whereby processing the fears and ritualised 
behaviours of OCD would decrease symptoms in the present before 
turning to work on the underlying events linked to the onset of 
symptoms. This study applied an EMDR protocol described by Marr 
(2012), where the treatment plan is in the following order: processing 
current triggers (OCD obsessions and compulsions which are viewed 
as separate recent traumatic events); installing a future template 
(imagining successful future action); and then processing any past 
related disturbing events. 
 
Cognitive Behavioural Therapy (CBT) 
CBT followed the ERP model (Foa, Yadin, & Lichner, 2012); for 
simplicity, we apply the acronym CBT to refer to exposure and 
response prevention in the rest of this manuscript. This treatment 
requires patients to become exposed to stimuli (i.e., situations, 
thoughts, sensations) that evoke obsessive thoughts and/or 
distressing feelings without performing the rituals that aim to reduce 
that distress (response prevention). Exposure can be in the form of 
actual (in-vivo) contact with anxiety-provoking stimuli or in 
imagination (imaginal exposure). These procedures are systematically 
repeated and typically organised along a hierarchical sequence of 
exposure tasks which escalate in difficulty. With repeated practice, the 
distress associated with stimuli that trigger obsessions decreases, and 
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the associated urges to ritualise also decrease (Foa et al., 2012). The 
treatment proceeded in five phases: (1) assessment and 
psychoeducation about OCD; (2) development of a case formulation 
and orientation to the treatment procedures; (3) collaborative 
development of an exposure hierarchy; (4) repeated ERP in-session 
and in-between sessions as homework practice; (5) development of a 
relapse prevention plan to overcome future setbacks. 
 
Standardisation and quality control 
 
Both treatments were standardised to 16-session protocols and were 
delivered by therapists (n = 12; 6 EMDR and 6 CBT) that were 
qualified in each of the treatment modalities (years of experience: 
EMDR = 2 to 7; CBT = 3 to 15). The majority of therapists had 
experience of working with OCD cases prior to the trial, except for 3 
EMDR therapists. Participating therapists had access to training 
sessions delivered by expert trainers in each of the treatment models; 
once prior to starting and once during the trial. Therapists also had 
access to group supervision and case discussion meetings for their 
respective treatments, approximately every 6 weeks. Their case notes 
were audited to ensure fidelity to the treatments and written feedback 
was provided by the study co-ordinator. No further fidelity checks or 
procedures were applied. 
 
Measures and data sources 
 
Primary outcome measure 
The Yale-Brown Obsessive Compulsive scale (YBOCS; Goodman et al 
1989) is a 10-item measure of OCD symptom severity; each item is 
rated from 0 (no symptoms) to 4 (extreme symptoms) yielding a total 
score between 0 ² 40 with excellent interrater reliability (ICC = .98) 
DQG LQWHUQDO FRQVLVWHQF\ ǂ  We applied the self-rated YBOCS 
developed by Baer et al. (1993), where a cut-RII 16 is commonly 
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applied to identify moderate to severe OCD symptoms (Baer et al., 
1993; Steketee, Frost, & Bogart, 1996). &URQEDFK·s alpha for the 
EDVHOLQH<%2&6LQWKLVVDPSOHZDVǂ  
 
Other measures 
The Mini International Neuropsychiatric Interview (MINI) was 
developed for use by lay interviewers as a short but accurate 
psychiatric diagnostic interview based on DSM-IV criteria (Sheehan, 
1998). The OCD module of the MINI can be delivered in person or over 
the telephone, with an average completion time of 15 minutes. The 
Obsessive Compulsive Inventory (OCI) is a 42-item questionnaire 
where respondents self-rate their distress levels (0 ² 4 Likert scale) on 
each item across 7 domains: washing, checking, doubting, ordering, 
obsessing, hoarding and mental neutralising (Foa et al., 1998). The 
total OCI score ranges between 0 ² 168 and has been found to 
correlate with the YBOCS (Foa et al., 1998). The PHQ-9 is a nine-item 
measure of depression symptoms (Kroenke, Spitzer, & Williams, 
2001); items are rated using a 4-point Likert scale (0 ² 3) yielding a 
total severity score between 0 ² 27. The GAD-7 is a seven-item 
measure of anxiety symptoms (Spitzer, Kroenke, Williams, & Löwe, 
2006); it is rated in the same way as the PHQ-9 yielding a total 
severity score between 0 ² 21. The Work and Social Adjustment Scale 
(WSAS) is a measure of functioning across five domains: work, home 
management, social leisure activities, private leisure activities, and 
family and relationships. Each item is rated between 0 (no 
impairment) and 8 (very severe impairment), with a total severity score 
between 0 ² 40. 
 De-identified demographic and clinical data were also collected 
for all consenting participants including age, gender, ethnicity, 
employment status, number of treatment sessions attended, and 
completion of agreed number of sessions (versus unilateral dropout). 
 
Recruitment, randomisation and data collection 
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As a feasibility trial, a formal sample size calculation was not 
estimated, but we aimed to recruit a minimum of 50 participants. All 
patients presenting to the service had telephone screening contacts 
with trained mental health practitioners as part of routine care. Those 
identified as presenting OCD symptoms at screening were referred to a 
telephone diagnostic interview with a researcher. All clinicians in the 
service were briefed about the recruitment process to ensure 
compliance. In addition, a researcher regularly reviewed waitlist 
records of primary diagnoses to identify any potential OCD cases that 
may have not been referred by screeners. 
 Patients who met MINI diagnostic criteria for OCD were invited 
to take part in the trial via telephone contacts, supplemented by a 
standard information sheet and consent form. Patients were excluded 
if (a) they did not meet criteria for OCD; or (b) OCD was not their 
primary reason for seeking treatment; or (c) they were using 
benzodiazepines; or (d) they were otherwise unsuitable for treatment 
in primary care (due to a history of psychotic or bipolar disorders, 
current suicidal risk, or current substance dependence). 
 Consenting participants were randomly assigned to either 
EMDR or CBT, using a computer-generated randomization schedule, 
by a research facilitator that was independent of the research and 
clinical teams. After randomization, participants were allocated to a 
trial therapist who prompted them to self-complete the YBOCS 
measure once per month (sessions 1, 4, 8, 12, 16). Secondary 
measures (PHQ-9, GAD-7, WSAS) were completed on a weekly basis, 
except for OCI which was only completed at the first and last 
treatment sessions. An independent researcher contacted all 
participants to gather (self-reported, paper-based) YBOCS measures at 
6 months follow-up, regardless of completion (or dropout) status. 
 
Statistical analyses 
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The analysis plan proceeded in three steps aiming (1) to assess the 
integrity of randomization by assessing the balance of characteristics 
in the randomised groups; (2) to assess the feasibility of delivering 
EMDR by comparing attendance and completion rates with CBT; (3) to 
compare clinical outcomes between groups based on intention-to-treat 
analysis. Cases with missing data (n = 9; 16.4%) were dealt with using 
multiple imputation based on an expectation maximization method 
(Schafer & Olsden, 1998). 
In step 1, we compared baseline characteristics between cases 
allocated to EMDR and CBT, using categorical (chi-square), 
parametric (t-tests) and non-parametric (Mann-Whitney U) tests 
according to the distribution of each variable. 
In step 2, we compared the percentage of cases completing 
treatment (versus dropouts) and those that provided 6-month follow-
up data between groups using chi-square analysis. We also compared 
the mean number of treatment sessions between groups using a 
Mann-Whitney U test, given the skewed distribution of data. 
In step 3, we used longitudinal multilevel modelling to examine 
the change (growth trend) in OCD symptoms over time, using a 2-level 
model with repeated YBOCS measures (level 1) nested within cases 
(level 2). Following conventional model building guidelines (Singer & 
Willett, 2003), we started by examining an unconditional (no 
predictors) model to determine the level of variance explained at each 
level. We then added covariates to the model, considered different 
covariance structures, assessed polynomial functions (i.e, quadratic, 
cubic) of covariates and assessed impact on model fit. Goodness of fit 
was assessed using ²2 log likelihood tests. After initial model 
checking, the primary analysis applied a 2-level linear growth model 
with unstructured covariance matrix. Covariates included baseline 
YBOCS severity, a group variable &%7 UHIHUHQFHFDWHJRU\FRGHG¶·
EMDR FRGHG ¶· DQG D JURXSWLPH LQWHUDFWLRQ WHUP which was 
defined as the main hypothesis test (changes in YBOCS over time 
across groups). Random effects included intercepts and time slopes. 
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This model was initially implemented up to the time when the 
treatment ended, and then extended to 6-months follow-up data. As a 
sensitivity analysis, the same approach was applied using a 3-level 
model with therapists as the third-level random effects. 
Raw means and standard deviations were used to calculate 
effect sizes &RKHQ·V d) at post-treatment and 6 months follow-up, 
adjusting for unequal sample sizes. 
Finally, we undertook some secondary and exploratory 
analyses. The numbers of cases attaining reliable and clinically 
significant improvement (RCSI) were compared between groups using 
chi-square analyses. A pre-post treatment reduction of 5 or more 
SRLQWV SOXV D ILQDO VFRUH RI <%2&6  KDV EHHQ WDNHQ WR LQGLFDWH
RCSI in prior outcome studies (Diefenbach et al., 2015). Post-
treatment scores in secondary outcome measures (OCI, PHQ-9, GAD-
7, WSAS) were compared using Mann-Whitney U tests, given their 
skewed distribution.  
We also assessed the rate of change in self-reported anxiety 
levels (GAD-7) up to session 16, by fitting non-linear growth trends in 
weekly time-series data for each treatment group. A cubic polynomial 
term was chosen based on the theoretical assumption that in-vivo 
exposure could increase anxiety before eventually leading to 
symptomatic improvements, thus potentially following an s-shaped 
(cubic) trend. 
 
RESULTS 
 
Random allocation and sample characteristics 
 
The CONSORT diagram in Figure 1 summarises the flow of 
participants through different stages of the trial. A total of 154 
patients were contacted as part of the recruitment process, of whom 
55 eligible and consenting participants were randomized and treated 
(EMDR = 29; CBT = 26). Table 1 presents sample characteristics for 
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trial participants; 61.8% were females, 41.8% were unemployed, 
90.4% were of white British background, with a mean age of 32.04 
(SD = 12.67) and mean YBOCS of 25.82 (SD = 6.40). Baseline severity 
estimates for secondary measures are also listed in Table 1. Statistical 
comparisons between the EMDR and CBT groups indicated no 
significant differences in any demographic or clinical characteristics 
(all p > .05). Therefore, randomization was adequate and yielded 
comparable samples. 
 
 
[Table 1] 
 
Feasibility analysis 
 
As shown in Table 2, the mean number of treatment sessions was 
10.49 (SD = 6.18), with no significant differences between groups; 
U(55) = 366.50, p = .86. Overall, 61.8% of participants completed their 
agreed number of treatment sessions (30.9% dropped out), with no 
significant differences in completion status between groups; x2(1) = 
0.35, p = .55. Similarly, 83.6% of cases provided 6 months follow-up 
data, with no significant differences in loss to follow-up between 
groups; x2(1) = 2.71, p = .10. 
 
[Table 2] 
 
Comparison of clinical outcomes 
 
The primary multilevel modelling indicated no significant main effects 
for the group*time interaction term at post-treatment (B = -1.28, SE = 
0.88, p = .16) or at 6 months follow-up (B = -0.11, SE = 0.42, p = .80). 
Main effects for time (post-treatment B = -2.66, SE = 0.63; 6 months B 
= -0.89, SE = 0.30) and baseline YBCOS (post-treatment B = 0.63, SE 
= 0.09; 6 months B = 0.57, SE = 0.10) were statistically significant in 
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all models (all p < .001). Figure 2 shows the gradual change in YBOCS 
at each of the measurement points; confidence intervals (dashed 
curves surrounding linear growth trends) clearly overlap for both 
treatment groups. These results were unchanged in sensitivity 
analyses controlling for therapist effects; main effects for group*time 
at post-treatment: B = -1.28, SE = 0.88, p = .16; 6 months: B = -0.11, 
SE = 0.44, p = .80; level-3 random effects: Z = 1.31, p = .19. 
 
[Figure 2] 
 
The YBOCS effect sizes were d = -0.24 (p = .38) post-treatment and d = 
-0.03 at 6 months follow-up (p = .90); where the negative sign favours 
the control group (CBT). Raw means used in effect size calculations 
are presented in Table 2, along with post-treatment estimates for 
secondary outcome measures, none of which were significantly 
different between groups (all p > .05). The proportions of cases 
attaining RCSI criteria were higher in the CBT group, though not 
statistically significant post-treatment (p = .14) or at 6 months follow-
up (p = .57). Figure 3 shows non-linear growth curves for weekly 
changes in anxiety symptoms across groups; there was no evidence of 
differential trends in the rate of change at early or later phases of 
treatment. 
 
[Figure 3] 
 
DISCUSSION 
 
Main findings 
 
This pragmatic trial is the first experimental demonstration that 
EMDR is feasible and safe to apply as a treatment for obsessive-
compulsive disorder in routine clinical care, by comparison to CBT. 
Attendance and completion rates were similar across groups, 
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indicating that EMDR was as well tolerated as CBT. Our analyses 
indicated that there were no significant differences between 
treatments in any of the outcome measures post-treatment or at 6 
months follow-up. We note, however, that this trial was not powered 
to detect small outcome differences between treatments (if these exist). 
Our preliminary effect size calculations yielded a small effect favouring 
CBT (d = -0.24), though this was not statistically significant and 
virtually disappeared at 6 months follow-up (d = -0.03). Furthermore, 
CBT cases were not more prone to dropout and we found no evidence 
that CBT cases experienced more intense anxiety at the early sessions 
of treatment by comparison to EMDR cases. These findings challenge 
the popular clinical notion that exposure can lead people to feel worse 
before they get better (Richard & Lauterbach, 2006). 
 
Strengths and limitations 
 
By comparison to earlier case-series, we recruited patients accessing a 
routine primary care setting and took steps to mitigate selection bias 
(such as screening waitlist records). We note that a considerable 
number of patients approached for screening did not consent to this 
(89 of 154; 58%). Nevertheless, the pre-treatment YBOCS mean (25.8) 
for the sample included in the trial was within the range of symptom 
severity reported in prior trials (21.8 to 28.7; reviewed by Fisher & 
Wells, 2005), so our sample was comparable to previous studies. 
 An important limitation concerns the sample size, which does 
not rule out the possibility that there could be small differences 
between treatments. The post-treatment effect size reported in this 
study could be used to calculate a sample size for future non-
inferiority trial designs. The funding and time constraints of this study 
did not enable us to undertake more stringent fidelity checks, such as 
ratings of video recorded sessions to assess adherence and 
competence of treatment delivery. This is also an important limitation, 
as we cannot be sure about the extent to which the interventions were 
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delivered with competence and fidelity to the respective treatment 
manuals. We note, however, that meta-analytic evidence indicates 
that there are no significant differences in effect sizes between OCD 
trials with and without treatment integrity checks (Olatunji et al., 
2013). Like most prior OCD trials (Eddy, Dutra, Bradley, & Western, 
2004; Rosa-Alcázar, Sánchez-Meca, Gómez-Conesa, & Marín-
Martínez, 2008), this study was also limited by a relatively brief follow-
up period which did not enable us to assess the maintenance of 
improvements beyond 6 months after treatment. 
 
Implications for theory and research 
 
Acknowledging the need for further replication in larger samples, the 
current evidence indicates that EMDR and CBT attain similar 
outcomes in the treatment of OCD. It is likely that some of the clinical 
effect in both interventions could be explained by common factors. For 
example, meta-analyses of several studies demonstrate that 
psychotherapy outcomes are influenced by the degree to which 
therapists are empathic (Elliott, Bohart, Watson, & Greenberg, 2011), 
foster a positive therapeutic alliance (Horvath, Del Re, Flückiger, & 
Symonds, 2011), HQKDQFH SDWLHQWV· H[SHFWDWLRQV Constantino et al., 
2011) and motivation to change (Norcross, Krebs, & Prochaska, 2011). 
Indeed, practice guidelines for OCD discuss the importance of these 
common factors to enhance collaboration and therapeutic change 
(Koran et al., 2007). 
Although common factors are important, previous studies 
comparing CBT with other active treatments or psychological placebo 
controls (relaxation training, stress and anxiety management) have 
reported small but statistically significant advantages favouring CBT 
(Olatunji et al., 2013). This leads us to think that common factors 
(presumed to be present in active control conditions) may offer a 
facilitative and therapeutic context within which specific change 
processes can be employed to enhance OCD symptom improvements. 
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The technical differences between treatments in this trial are not 
enlightening in this regard, since EMDR patients improved without 
being directed towards in-vivo exposure and CBT patients improved 
without bilateral stimulation or the processing of past memories. On 
the other hand, it is plausible that EMDR and CBT apply similar 
change processes, which are more specific than the common 
facilitative factors described above. 
The most apparent shared change mechanism is that of 
exposure to anxiety-provoking stimuli, which EMDR applies 
imaginally (i.e., in imagination) and CBT applies both imaginally and 
in-vivo (Foa et al., 2012). Previous studies have shown that treatments 
that combine in-vivo plus imaginal exposure attain better outcomes 
than exposure in-vivo alone (Rosa-Alcázar et al., 2008). Hence it is 
possible that imaginal exposure is a key shared component that 
enhances therapeutic change. Wolpe described the successful 
WUHDWPHQWRIDQ[LHW\WKURXJKLPDJLQDOH[SRVXUHDVHDUO\DVWKH·V
(Wolpe, 1958), leading to the eventual development of emotional 
processing theory which informs ²to some extent² the hypothesis of 
systematic desensitization that is common to EMDR and ERP. From 
this perspective, one possible explanation for our results is that 
patients in both groups attained some degree of desensitization to 
obsessional thoughts, and (repeated and prolonged) imaginal exposure 
is sufficient to achieve this. In fact, both treatments aim to observe 
within-session-habituation, as reported by the patient in subjective 
units of distress. 
Even though emotional processing theory is still widely accepted 
by clinicians, there are some contradictory findings that challenge the 
basic tenets of habituation. For example, studies have shown that 
within-session-habituation does not necessarily correlate with longer 
term anxiety reduction (Baker et al., 2010), fears can often be 
spontaneously reinstated after extinction (Craske & Mystkowski, 
2006), and successful fear reduction can occur in the absence of 
exposure (Rachman, Craske, Tallman, & Solyom, 1986). An alternative 
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perspective could be offered by contemporary theories on the 
mechanisms of fear acquisition and inhibitory learning. Supported by 
numerous laboratory and clinical studies (see Craske et al., 2014), 
inhibitory learning theory posits that a learned association between 
conditioned and unconditioned stimuli (CS-US) is not entirely 
eradicated during extinction (i.e., during exposure procedures). The 
original CS-US pairing is left intact as a memory, while a new and 
secondary learning set is formed (CS no-US) that serves to inhibit and 
effectively compete against the original set. Concerning OCD 
treatment, it is possible that CBT (ERP results in disconfirmation of 
feared expectations) and EMDR (installation of a positive cognition 
competes against feared expectations) facilitate inhibitory learning in 
slightly different ways, which accounts for distress reduction over time 
with secondary gains in self-efficacy and functioning. Overall, aside 
from common facilitative factors, it is plausible that both EMDR and 
CBT rely extensively on shared change mechanisms such as exposure 
and reappraisal strategies. While our theoretical interpretations are 
largely speculative, future studies could aim to investigate possible 
mechanisms of action which may be common to treatments that 
involve imaginal exposure and inhibitory learning processes for the 
treatment of OCD.  
In conclusion, both treatments studied in this trial had similar 
effects in the treatment of OCD, although it is important to remark 
that some patients dropped out and did not attain symptom 
improvements. It is possible that some may find one or the other 
treatment more tolerable, credible or acceptable. Future qualitative 
studies focusing on acceptability and investigations of mechanisms of 
change may help us to better understand how to maximise the 
effectiveness of psychological treatments for OCD. 
 19 
 
ACKNOWLEDGEMENT 
 
We gratefully acknowledge the following colleagues who 
supported the development and conduct of the trial: John Marr, 
Alexander Teahan, Rebecca Forster, Clare Burdekin, Sally Downie, 
Kirsteen Johnson, Laura Johnson, Naomi Kirby, Ian McAleer, Janet 
Thomson, Matthew Garner, Lorraine McLaren, Nicole Connor, Linda 
Dobrzanska and Bernie Bell. 
 The ECO Trial (EMDR vs. CBT for OCD) was funded by Leeds 
Community Healthcare NHS Trust. The funding organisation had no 
role in the design of the trial or the decision to publish the results. 
 20 
 
REFERENCES 
 
Abramowitz, J. S. (1997). Effectiveness of psychological and 
pharmacological treatments for obsessive²compulsive disorder: a 
quantitative review. Journal of Consulting and Clinical Psychology, 
65(1), 44²52. DOI: 10.1037/0022-006X.65.1.44 
 
Abramowitz, J. S. (1998). Does cognitive²behavioral therapy cure 
obsessive²compulsive disorder? A meta-analytic evaluation of clinical 
significance. Behavior Therapy, 29, 339²355. DOI: 10.1016/S0005-
7894(98)80012-9 
 
Abramowitz, J. S., Taylor, S., & McKay, D. (2005). Potentials and 
limitations of cognitive therapy for obsessive-compulsive disorder. 
Cognitive Behaviour Therapy, 34, 140-147. DOI: 
10.1080/16506070510041202 
 
Abramowitz, J. S., Taylor, S., & McKay, D. (2009). Obsessive-
compulsive disorder. The Lancet, 374, 491²499. DOI: 10.1016/S0140-
6736(09)60240-3 
 
Baer, L., Brown-Beasley, M. W., Sorce, J., & Henriques, A. I. (1993). 
Computer-assisted telephone administration of a structured interview 
for obsessive²compulsive disorder. American Journal of Psychiatry, 
150, 1737²1738. DOI: 10.1176/ajp.150.11.1737 
 
Baker, A., Mystkowski, J., Culver, N., Yi, R., Mortazavi, A., & Craske, 
M. G. (2010). Does habituation matter? Emotional processing theory 
and exposure therapy for acrophobia. Behaviour Research and 
Therapy, 48(11), 1139²1143. DOI: 10.1016/j.brat.2010.07.009 
 
 21 
Bekkers, A.F.M.I. (1999). Enige ervaringen met EMDR bij dwang. In: 
Haaijman, W.P., Diepstraten, Ph.H.J., van Schevikhoven, R.E.O. (eds), 
Ongewoon en anders. 25 jaar kliniek Overwaal te Lent. 
 
Bisson, J. I., Ehlers, A., Matthews, R., Pilling, S., Richards, D., & 
Turner, S. (2007). Psychological treatments for chronic post-traumatic 
stress disorder: Systematic review and meta-analysis. British Journal 
of Psychiatry, 190ï DOI: 10.1192/bjp.bp.106.021402 
 
Bohm, K., Volderholzer. U, (2010) Use of EMDR in the Treatment of 
Obsessive Compulsive Disorder: A Case Series. Verhaltenstherapie, 20, 
175-181. DOI: 10.1159/000319439 
 
Constantino, M. J., Glass, C. R., Arnkoff, D. B., Ametrano, R. M., & 
Smith, J. Z. (2011). Expectations. In J. C. Norcross (Ed.), 
Psychotherapy relationships that work: Evidence-based responsiveness 
(2nd ed., pp. 354 ²376). New York, NY: Oxford University Press, Inc. 
 
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & 
Petticrew, M. (2008). Developing and evaluating complex 
interventions: The new Medical Research Council guidance. British 
Medical Journal, 337, a1655. DOI: 10.1136/bmj.a1655 
 
Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. 
(2014). Maximizing exposure therapy: An inhibitory learning 
approach. Behaviour Research and Therapy, 58, 10²23. DOI: 
10.1016/j.brat.2014.04.006 
 
Craske, M. G., & Mystkowski, J. (2006). Exposure therapy and 
extinction: clinical studies. In M. G. Craske, D. Hermans, & D. 
Vansteenwegen (Eds.), Fear and learning: Basic science to clinical 
application. Washington, DC: APA Books. 
 
 22 
Davidson, P.R., Parker, K.C. (2001). Eye movement desensitization 
and reprocessing (EMDR): a meta-analysis. Journal of Consulting and 
Clinical Psychology, 69, 305²316. DOI: 10.1037/0022-006X.69.2.305 
 
De Silva, P., Marks, M. (1999). The role of traumatic experiences in 
the genesis of obsessive-compulsive disorder. Behaviour Research and 
Therapy, 37, 941-951. DOI: 10.1016/S0005-7967(98)00185-5 
 
Diefenbach, G.J., Wootton, B.M., Bragdon, L.B., Moshier, S.J., Tolin, 
D.F. (2015). Treatment Outcome and Predictors of Internet Guided 
Self-Help for Obsessive-Compulsive Disorder. Behavior Therapy, 46, 
764-774. DOI: 10.1016/j.beth.2015.06.001 
 
Eddy, K. T., Dutra, L., Bradley, R., & Westen, D. (2004). A 
multidimensional meta-analysis of psychotherapy and 
pharmacotherapy for obsessive²compulsive disorder. Clinical 
Psychology Review, 24ï. DOI: 10.1016/j.cpr.2004.08.004 
 
Elliott, R., Bohart, A. C., Watson, J. C., & Greenberg, L. S. (2011). 
Empathy. Psychotherapy, 48, 43-49. DOI: 10.1037/a0022187 
 
Fisher, P.L., & Wells, A. (2005). How effective are cognitive and 
behavioral treatments for obsessive²compulsive disorder? A clinical 
significance analysis. Behaviour Research and Therapy, 43, 1543²
1558. DOI: 10.1016/j.brat.2004.11.007 
 
Foa, E.B., Kozak, M.J., Salkovskis, P.M., Coles, M.E., Amir,N. (1998). 
The validation of a new obsessive²compulsive disorder scale: The 
Obsessive²Compulsive Inventory. Psychological Assessment, 10(3), 
206-214. DOI: 10.1037/1040-3590.10.3.206 
 
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., 
Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. 
 23 
B., Simpson, H. B., & Tu, X. (2005). Treatment of obsessive-
compulsive disorder by exposure and ritual prevention, clomipramine, 
and their combination: a randomized, placebo controlled trial. 
American Journal of Psychiatry, 162, 151²161. DOI: 
10.1176/appi.ajp.162.1.151 
 
Foa, E.B., Yadin, E.,& Lichner, T.K. (2012). Exposure and Response 
(Ritual) Prevention for Obsessive-Compulsive Disorder. New York: 
Oxford University Press. 
 
Goodman, W. K., Price L. H., Rasmussen, S. A., Mazure, C., 
Fleishmann, R. L., Hill, C. L., Heninger, G.R., Charney, D.S. (1989). 
The Yale-Brown Obsessive Compulsive Scale. I. Development, use and 
reliability. Archives of General Psychiatry, 46, 1006-1011. 
 
Helzer, J. E., Robins, L. N., & McEvoy, L. (1987). Posttraumatic stress 
disorder in the general population: Findings of the Epidemiologic 
Catchment Area Survey. New England Journal of Medicine, 317, 1630-
1634. DOI: 10.1056/NEJM198712243172604 
 
Horvath, A., Del Re, A. C., Flückiger, C., & Symonds, D. (2011). 
Alliance in individual psychotherapy. Psychotherapy, 48, 9-16. DOI: 
10.1037/a0022186 
 
Jordan, B. K., Schlenger, W. E., Hough, R., Kulka, R. A., Weiss, D., & 
Fairbank, J. A. (1991). Lifetime and current prevalence of specific 
psychiatric disorders among Vietnam veterans and controls. Archives 
of General Psychiatry, 48, 207-215. DOI: 
10.1001/archpsyc.1991.01810270019002 
 
Keenan, P., Keenan, L., Ingham, C., and Farrell, D. (2014). Treating 
obsessive compulsive disorder using eye movement desensitisation and 
reprocessing (EMDR): A case series design. In: EMDR research 
 24 
symposium. Symposium presented at 15th EMDR Europe Association 
Conference, Edinburgh, Scotland 
 
Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. (2007). 
Practice guideline for the treatment of patients with obsessive-
compulsive disorder. American Journal of Psychiatry, 164, 5-53. 
 
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: 
Validity of a brief depression severity measure. Journal of General 
Internal Medicine, 16, 606²613. DOI: 10.1046/j.1525-
1497.2001.016009606.x 
 
Marr, J. (2012). EMDR treatment of obsessive-compulsive disorder: 
Preliminary research. Journal of EMDR Practice and Research, 6, 2-15. 
DOI: 10.1891/1933-3196.6.1.2 
 
National Institute for Health and Clinical Excellence. (2005). 
Obsessive-compulsive disorder: Core interventions in the treatment of 
obsessive-compulsive disorder and body dysmorphic disorder. London: 
NICE. 
 
National Institute for Health and Clinical Excellence (2011). Common 
Mental Health Disorders: identification and pathways to care. London: 
National Collaborating Centre for Mental Health. 
 
Nazari, H., Momeni, N., Jariani, M., Mohammad, JT. (2011). 
Comparison of eye movement desensitization and reprocessing with 
citalopram in treatment of obsessive-compulsive disorder. 
International Journal of Psychiatry in Clinical Practice, 15, 270-274. 
DOI: 10.3109/13651501.2011.590210 
 
Norcross, J. C., Krebs, P. M., & Prochaska, J. O. (2011). Stages of 
change. In J. C. Norcross (Ed.), Psychotherapy relationships that work: 
 25 
Evidence-based responsiveness (2nd ed., pp. 279 ²300). New York, NY: 
Oxford University Press, Inc. 
 
Olatunji, B. O., Davis, M. L., Powers, M. B., & Smits, J. A. (2013). 
Cognitive-behavioral therapy for obsessive-compulsive disorder: A 
meta-analysis of treatment outcome and moderators. Journal of 
Psychiatric Research, 47, 33²41. DOI: 
10.1016/j.jpsychires.2012.08.020 
 
Ponniah, K., Magiati, I., & Hollon, S. D. (2013). An update on the 
efficacy of psychological treatments for obsessive-compulsive disorder 
in adults. Journal of Obsessive-Compulsive and Related Disorders, 2, 
207-218. DOI: 10.1016/j.jocrd.2013.02.005 
 
Rachman, S. J., Craske, M. G., Tallman, K., & Solyom, C. (1986). 
Does escape behaviour strengthen agoraphobic avoidance? A 
replication. Behavior Therapy, 17, 366²384. DOI: 10.1016/S0005-
7894(86)80069-7 
 
Richard, D. C. S., & Lauterbach, D. L. (2006). Handbook of exposure 
therapies. New York: Academic Press 
 
Rosa-Alcázar AI, Sánchez-Meca J, Gómez-Conesa A, Marín-Martínez 
F. (2008). Psychological treatment of obsessive-compulsive disorder: a 
meta-analysis. Clinical Psychology Review, 28, 1310-25. DOI: 
10.1016/j.cpr.2008.07.001 
 
Rowa, K., Antony, M. M., Summerfeldt, L. J., Purdon, C., Young, L. 
and Swinson, R. P. (2007). Office-based vs. home-based behavioral 
treatment for obsessive-compulsive disorder: a preliminary study. 
Behavior Research and Therapy, 45, 1883²1892. DOI: 
10.1016/j.brat.2007.02.009 
 
 26 
Schafer, J. L., & Olsden, M. K. (1998). Multiple imputation for 
multivariate missing-data problems: A data analyst's perspective. 
Multivariate Behavioral Research, 33, 545-571. DOI: 
10.1207/s15327906mbr3304_5 
 
Shapiro, F. (2001). Eye Movement desensitization and reprocessing: 
Basic principles, protocols, and procedures. New York: Guilford Press. 
 
Shapiro, F., Forrest, M. (2004). EMDR: The breakthrough therapy for 
overcoming anxiety, stress and trauma. New York: Perseus Books 
Group. 
 
Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P. & Janavs, J. 
(1998). The Mini-International Neuropsychiatric Interview (MINI): the 
development and validation of a structured diagnostic psychiatric 
interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 
22²33. 
 
Singer, J., & Willett, J. (2003). Applied longitudinal data analysis: 
Modeling change and event occurrence. New York: Oxford University. 
 
Spitzer, R., Kroenke, K., Williams, J. B. W., & Lowe, B. (2006). A brief 
measure for assessing generalized anxiety disorder: The GAD-7. 
Archives of Internal Medicine, 166, 1092²1097. DOI: 
10.1001/archinte.166.10.1092 
 
Steketee, G. (1993). Social support and treatment outcome of 
obsessive compulsive disorder at 9-month follow-up. Behavioural and 
Cognitive Psychotherapy, 21, 81-95. DOI: 
10.1017/S014134730001805X 
 
 27 
Steketee, G., Frost, R., & Bogart, K. (1996). The Yale-Brown Obsessive 
Compulsive Scale: Interview versus self-report. Behaviour Research 
and Therapy, 34, 675-684. DOI: 10.1016/0005-7967(96)00036-8 
 
van Balkom, A. J. L. M., van Oppen, P., Vermeulen, A. W. A., van 
Dyck, R., Nauta, M. C. E., & Vorst, H. C. M. (1994). A meta-analysis 
on the treatment of obsessive compulsive disorder: a comparison of 
antidepressants, behavior, and cognitive therapy. Clinical Psychology 
Review, 14, 359²381. DOI: 10.1016/0272-7358(94)90033-7 
 
van Oppen, P., Emmelkamp, P.M.G., van Balkom, A.J.L.M., and van 
Dyck, R. (1995). The Sensitivity to Change of Measures for Obsessive-
Compulsive Disorder. Journal of Anxiety Disorders, 9, 241-248. DOI: 
10.1016/0887-6185(95)00005-9 
 
Van Etten, M.L., Taylor, S. (1998). Comparative efficacy of treatments 
for post-traumatic stress disorder: a meta-analysis. Clinical 
Psychology & Psychotherapy, 5, 126-144. DOI: 10.1002/(SICI)1099-
0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H 
 
Wolpe, J. (1958). Psychotherapy by reciprocal inhibition. Stanford: 
Stanford University Press. 
 
 28 
Figure 1.  CONSORT diagram 
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Figure 2.  Linear growth trends and confidence intervals for 
YBOCS measures 
 
 
 
 
[Figure legend] 
Solid lines = YBOCS linear growth trend; dashed curves = 95% confidence intervals; 
EMDR = eye-movement desensitization and reprocessing; CBT = cognitive 
behavioural therapy; f/up = follow-up 
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Figure 3.  Non-linear growth trends and confidence intervals for 
weekly anxiety (GAD-7) measures 
 
 
 
[Figure legend] 
Solid curves = GAD-7 cubic growth trend; dashed curves = 95% confidence intervals; 
EMDR = eye-movement desensitization and reprocessing; CBT = cognitive 
behavioural therapy 
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Table 1. Sample characteristics and comparisons between groups 
 
 
 Full sample EMDR group CBT group test statistic p 
 N = 55 (100%) N = 29 (52.7%) N = 26 (47.3%)   
Demographics 
Females 34 (61.8) 17 (58.6) 17 (65.4) x2(1)=0.26 .61 
Mean age (SD) 32.04 (12.67) 30.90 (9.79) 33.31 (15.37) U(55)=376.00 .99 
Unemployed 23 (41.8) 14 (48.3) 17 (65.4) x2(1)=1.05 .31 
Ethnicity*      
       White British 47 (90.4) 23 (88.5) 24 (92.3) x2(1)=0.22 .64 
       Other 5 (9.6) 3 (11.5) 2 (7.7)   
Baseline severity measures 
YBOCS mean (SD) 25.82 (6.40) 25.07 (6.23) 26.65 (6.61) t (53)=0.92 .36 
OCI mean (SD) 71.13 (30.19) 73.93 (28.94) 68.12 (31.80) t (50)=-0.69 .49 
PHQ-9 mean (SD) 12.40 (6.58) 11.86 (6.30) 13.04 (6.98) t (50)= 0.64 .52 
GAD-7 mean (SD) 14.38 (5.06) 13.64 (5.45) 15.25 (4.53) U(52)=283.50 .33 
WSAS mean (SD) 18.51 (10.21) 17.81 (10.19) 19.29 (10.39) t (49)= 0.51 .61 
CBT = cognitive behavioural therapy; EMDR = eye movement desensitization and reprocessing; YBOCS = Yale-Brown Obsessive Compulsive Scale; OCI = Obsessive Compulsive 
Inventory; PHQ-9 = measure of depressions symptoms; GAD-7 = measure of anxiety symptoms; WSAS = work and social adjustment scale; t  6WXGHQW·VW-test; U = Mann-Whitney 
U test; x2 = Chi-square test; * percentages exclude 3 cases with missing data
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Table 2. Comparison of treatment outcomes between groups 
 
 
 Full sample EMDR group CBT group test statistic p 
 N = 55 (100%) N = 29 (52.7%) N = 26 (47.3%)   
Attendance and follow-up data 
Mean treatment sessions (SD) 10.49 (6.18) 10.17 (6.63) 10.85 (5.73) U(55)=366.50 .86 
Completion status*      
       Completed 34 (61.8) 17 (58.6) 17 (65.4) x2(1)= 0.35 .55 
       Dropped out 17 (30.9) 10 (34.5) 7 (26.9)   
       Referred onwards 4 (7.3) 2 (6.9) 2 (7.7)   
Assessed @6 months follow-up 46 (83.6) 22 (75.9) 24 (92.3) x2(1)= 2.71 .10 
Outcomes data      
Post-treatment outcomes      
       YBOCS mean (SD) 17.75 (8.69) 18.72 (8.01) 16.65 (9.43) t (53)= -0.88 .38 
       YBOCS RCSI**  16/53 (30.2) 6/28 (21.4) 10/25 (40.0) x2(1)= 2.16 .14 
       OCI mean (SD) 46.78 (35.22) 47.90 (33.24) 45.54 (37.93) U(55)=403.50 .66 
       PHQ-9 mean (SD) 7.64 (7.03) 7.55 (6.99) 7.73 (7.20) U(55)=370.00 .91 
       GAD-7 mean (SD) 8.96 (6.09) 9.14 (6.18) 8.77 (6.10) U(55)=390.00 .83 
       WSAS mean (SD) 10.91 (9.76) 11.17 (9.33) 10.62 (10.40) U(55)=402.00 .67 
6 months follow-XSRXWFRPHVʕ      
       Mean YBOCS score (SD) 18.09 (9.55) 18.24 (8.59) 17.92 (10.69) t (53)= -0.12 .90 
       YBOCS RCSI** 15/53 (28.3) 7/28 (25.0) 8/25 (32.0) x2(1)= 0.32 .57 
CBT = cognitive behavioural therapy; EMDR = eye movement desensitization and reprocessing; YBOCS = Yale-Brown Obsessive Compulsive Scale; OCI = Obsessive Compulsive 
Inventory; PHQ-9 = measure of depressions symptoms; GAD-7 = measure of anxiety symptoms; WSAS = work and social adjustment scale; RCSI = reliable and clinically 
significant improvement; t  6WXGHQW·VW-test; U = Mann-Whitney U test; x2 = Chi-square test; * statistical comparisons made between completers vs. dropouts; ** comparisons 
made between cases that scored above YBOCS cut-RIIʕFDOFXODWHGXVLQJLPSXWHGPRQWKVRXWFRPHVGDWD 
